» Articles » PMID: 33131371

Heart Failure with Preserved Ejection Fraction: Disease Burden for Patients, Caregivers, and the Health-care System

Overview
Journal Postgrad Med
Publisher Informa Healthcare
Specialty General Medicine
Date 2020 Nov 2
PMID 33131371
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

Heart failure with preserved ejection fraction (HFpEF) will soon become the most prevalent form of HF because of an aging population and an accompanying increase in the number of risk factors for this disease. The high frequency of comorbidities typical of this population contributes to an increased risk for hospitalization and death. It is also partially responsible for the symptomatic deterioration that results in hospitalization and impaired quality of life and functional capacity in patients. The effects of HFpEF are felt by patients and their caregivers, who might experience detriment to their own health and their social and working lives. Financial burden is associated with HFpEF, stemming from hospitalization and long-term care costs, as well as absenteeism from work in the case of caregivers. Early identification of patients at risk and aggressive management are key to preventing this disease and its progression.

Citing Articles

Mechanistic Relevance of Ventricular Arrhythmias in Heart Failure with Preserved Ejection Fraction.

Bahrami P, Aromolaran K, Aromolaran A Int J Mol Sci. 2025; 25(24.

PMID: 39769189 PMC: 11677834. DOI: 10.3390/ijms252413423.


Association of Palliative Care Consultation in Patients With Heart Failure With Preserved Ejection Fraction With Symptom Burden and Health Care Use.

Warraich H, Godfrey S, Makwana B, Abraham S, Aglan A, Saji A JACC Adv. 2024; 4(1):101431.

PMID: 39697769 PMC: 11653141. DOI: 10.1016/j.jacadv.2024.101431.


Evaluating the Prognostic Value of the Modified HFPEF Score in Patients With Heart Failure With Preserved Ejection Fraction.

Jin Y, Geng L, Li Y, Wang K, Xiao B, Wang M Cardiol Res. 2024; 15(5):358-368.

PMID: 39420974 PMC: 11483114. DOI: 10.14740/cr1635.


Assessment of the diagnostic value of NT-proBNP in heart failure with preserved ejection fraction.

Birrell H, Isles C, Fersia O, Anwar M, Mondoa C, McFadyen A Br J Cardiol. 2024; 31(1):002.

PMID: 39323949 PMC: 11421065. DOI: 10.5837/bjc.2024.002.


SGLT2 Inhibition in Heart Failure with Preserved Ejection Fraction - The New Frontier.

Aguiar-Neves I, Santos-Ferreira D, Fontes-Carvalho R Rev Cardiovasc Med. 2024; 24(1):1.

PMID: 39076855 PMC: 11270412. DOI: 10.31083/j.rcm2401001.